These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22890743)

  • 1. Hair regrowth in a male patient with extensive androgenetic alopecia on estrogen therapy.
    Adenuga P; Summers P; Bergfeld W
    J Am Acad Dermatol; 2012 Sep; 67(3):e121-3. PubMed ID: 22890743
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.
    Hoedemaker C; van Egmond S; Sinclair R
    Australas J Dermatol; 2007 Feb; 48(1):43-5. PubMed ID: 17222303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and tolerability of 5% minoxidil solution (Carexidil®) in male and female androgenetic alopecia: a 6-month open multicentric study].
    Piraccini B; Starace M; Alessandrini A; Guarrera M; Fiorucci MC; Lorenzi S
    G Ital Dermatol Venereol; 2011 Dec; 146(6 Suppl 1):1-8. PubMed ID: 22189834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride.
    Walsh DS; Dunn CL; James WD
    Arch Dermatol; 1995 Dec; 131(12):1373-5. PubMed ID: 7492124
    [No Abstract]   [Full Text] [Related]  

  • 5. Relation between treatment efficacy and cumulative dose of 3% topical minoxidil in male pattern baldness.
    Choi JW; Na SY; Park KC; Youn SW; Huh CH
    J Am Acad Dermatol; 2012 Jan; 66(1):e10-2. PubMed ID: 22177646
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls.
    Olamiju B; Craiglow BG
    J Am Acad Dermatol; 2021 Jun; 84(6):1689-1691. PubMed ID: 33333154
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical effect of JetpPeel-assisted topical minoxidil in the treatment of androgenetic alopecia: A randomized pilot study.
    Gong L; Bao L; Tian T; Li Y
    J Cosmet Laser Ther; 2018 Feb; 20(1):58-63. PubMed ID: 29166130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
    Koperski JA; Orenberg EK; Wilkinson DI
    Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of topical minoxidil 5% and adenosine 0.75% solutions on male androgenetic alopecia and measuring patient satisfaction rate.
    Faghihi G; Iraji F; Rajaee Harandi M; Nilforoushzadeh MA; Askari G
    Acta Dermatovenerol Croat; 2013; 21(3):155-9. PubMed ID: 24183218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding and managing common baldness.
    Tran D; Sinclair RD
    Aust Fam Physician; 1999 Mar; 28(3):248-50, 252-3. PubMed ID: 10098304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical estrogen therapy for androgenetic alopecia in menopausal females.
    Georgala S; Katoulis AC; Georgala C; Moussatou V; Bozi E; Stavrianeas NG
    Dermatology; 2004; 208(2):178-9. PubMed ID: 15057016
    [No Abstract]   [Full Text] [Related]  

  • 12. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.
    Sinclair RD
    Int J Dermatol; 2018 Jan; 57(1):104-109. PubMed ID: 29231239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male pattern baldness.
    Hogan DJ; Chamberlain M
    South Med J; 2000 Jul; 93(7):657-62. PubMed ID: 10923949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of minoxidil high extra combination therapy in patients with androgenetic alopecia.
    Pazoki-Toroudi H; Babakoohi S; Nilforoushzadeh MA; Nassiri-Kashani M; Shizarpour M; Ajami M; Habibey R; Sadr B; Rashighi-Firoozabadi M; Firooz A
    Skinmed; 2012; 10(5):276-82. PubMed ID: 23163069
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of minoxidil on hair growth in androgenic alopecia in women].
    Brzezińska-Wcisło L
    Pol Merkur Lekarski; 2002 Sep; 13(75):208-11. PubMed ID: 12474572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal.
    Tosti A; Iorizzo M; Vincenzi C
    Arch Dermatol; 2003 Sep; 139(9):1221-2. PubMed ID: 12975176
    [No Abstract]   [Full Text] [Related]  

  • 17. The therapeutic use of topical minoxidil.
    DeVillez RL
    Dermatol Clin; 1990 Apr; 8(2):367-75. PubMed ID: 2191807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of minoxidil in chemotherapy-induced alopecia.
    Duvic M; Lemak NA; Valero V; Hymes SR; Farmer KL; Hortobagyi GN; Trancik RJ; Bandstra BA; Compton LD
    J Am Acad Dermatol; 1996 Jul; 35(1):74-8. PubMed ID: 8682968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C's of oral therapy.
    Beach RA
    Dermatol Ther; 2018 Nov; 31(6):e12707. PubMed ID: 30246901
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of hormonal therapy for female pattern (androgenic) alopecia.
    Scheinfeld N
    Dermatol Online J; 2008 Mar; 14(3):1. PubMed ID: 18627703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.